KROS Keros Therapeutics

• $76K bought by 1 insider
• None no sales outside a trading plan
• $96K sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Charles W. Newton Director
   Planned sale
   $5,675 551 shares at $10.30 4.4% of stake
   Traded Aug 18 Filed Aug 20
   ↗
3. Jean Jacques Bienaime Director
   Buy
   $10K 1,000 shares at $10.27 +5.4% to stake
   Traded Aug 17 Filed Aug 19
   ↗
4. Jean Jacques Bienaime Director
   Buy
   $11K 1,000 shares at $10.61 +5.7% to stake
   Traded Jul 15 Filed Jul 17
   ↗
5. Jean Jacques Bienaime Director
   Buy
   $10K 1,000 shares at $10.19 +6% to stake
   Traded Jun 15 Filed Jun 17
   ↗
6. Charles W. Newton Director
   Planned sale
   $5,522 550 shares at $10.04 4.2% of stake
   Traded Jun 11 Filed Jun 15
   ↗
7. Julius Knowles Director
   Planned sale
   $28K 2,625 shares at $10.73 19% of stake
   Traded Jun 4 Filed Jun 8
   ↗
8. Alpna Seth Director
   Planned sale
   $28K 2,625 shares at $10.72 21% of stake
   Traded Jun 4 Filed Jun 5
   ↗
9. Jean Jacques Bienaime Director
   Buy
   $11K 1,000 shares at $10.58 +12% to stake
   Traded May 15 Filed May 19
   ↗
10. Jean Jacques Bienaime Director
    Buy
    $12K 1,000 shares at $11.70 +13% to stake
    Traded Apr 15 Filed Apr 17
    ↗
11. Jean Jacques Bienaime Director
    Buy
    $22K 2,000 shares at $11.21 +37% to stake
    Traded Mar 9 Filed Mar 11
    ↗
12. Tomer Kariv Director, +7 joint filers
    Sale
    $85M 4,787,331 shares at $17.75 100% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025
    ↗
13. ADAR1 Capital Management, LLC 10% owner, +3 joint filers
    Sale
    $95.7M 5,389,264 shares at $17.75 100% of stake
    Traded Oct 15, 2025 Filed Oct 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 7 stock grants, 7 sales to cover taxes, 6 sales back to the company, and 1 option exercise.